Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B |
| |
| Authors: | Hyo Jung Cho Soon Sun Kim Seun Joo Ahn Joo Han Park Dong Joon Kim Young Bae Kim Sung Won Cho Jae Youn Cheong |
| |
| Affiliation: | 1.Department of Gastroenterology, Hallym University College of Medicine, Chuncheon, Korea.;2.Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.;3.Department of Pathology, Ajou University School of Medicine, Suwon, Korea. |
| |
| Abstract: | Background/AimsTransferrin and alpha-1 antitrypsin are reportedly associated with liver fibrosis. We evaluated the usefulness of serum transferrin and alpha-1 antitrypsin as new liver fibrosis markers in patients with chronic hepatitis B.MethodsThe study included 293 patients with chronic hepatitis B who underwent a liver biopsy between October 2005 and June 2009, and who had no history of hepatocellular carcinoma. Serum markers and liver fibrosis stages were compared.ResultsUnivariate analysis revealed that age (P<0.001), serum platelet count (P<0.001), and serum alkaline phosphatase level (P=0.003) differed significantly between the patients with and without liver cirrhosis. Serum transferrin levels were significantly lower in advanced fibrosis than in mild fibrosis in both univariate analysis (P=0.002) and multivariate analysis (P=0.009). In addition, the serum transferrin level was significantly lower in cirrhotic patients than in noncirrhotic patients (P=0.020). However, the serum level of alpha-1 antitrypsin was not significantly associated with liver cirrhosis in patients with chronic hepatitis B.ConclusionsSerum transferrin could be promising serum marker for predicting advanced liver fibrosis in patients with chronic hepatitis B. |
| |
| Keywords: | Chronic hepatitis B Liver cirrhosis Transferrin Alpha-1 antitrypsin |
|
|
